CAMP Continuation Study/Phase 2

CAMP 继续研究/第 2 阶段

• 批准号: 7095107
• 负责人: ANNE L FUHLBRIGGE
• 金额: $ 32.06万
• 依托单位: BRIGHAM AND WOMEN'S HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2003
• 资助国家: 美国
• 起止时间: 2003-09-30 至 2007-09-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7095107
• 关键词: adolescence (12-20); asthma; blood chemistry; clinical research; data collection methodology /evaluation; densitometry; longitudinal human study; medical outreach /case finding; middle childhood (6-11); patient care management; patient care planning; questionnaires; respiratory function

This application if for the Harvard Vanguard Medical Associates (HVMA) to participate in the Childhood Asthma Management Program Continuation Study/Phase 2 (CAMPCS/2). The abstract and, research p_a0 for CAMPCS/2 are included in the application for the Washington University (Robert Strunk, PI). This HVMA clinic is committed to participating in CAMPCS/2 and supports the continued follow up of CAMP patients. We will continue to collect data of high quality. We enrolled 124 patients in CAMP and enrolled 115 patients in CAMPCS. The families and patients of CAMPCS continue to be committed to the study and we anticipate their continued involvement through CAMPCS/2. We have successfully recruited 94% of the original CAMP cohort into CAMPCS, and we will continue to recruit the original CAMP cohort for CAMPCS/2. Participation in CAMPCS has been excellent with 94-97% of patients completing CAMPCS study visits for which the completion window has closed.

该申请如果哈佛先锋医疗伙伴（HVMA）参加 儿童哮喘管理计划延续研究/第2阶段（CAMPCS/2）。 华盛顿大学（Robert Strunk，PI）的摘要和CAMCCS/2的研究P_A0包括在内。 该HVMA诊所致力于参加CAMCCS/2，并支持CAMP患者的持续随访。我们将继续收集高质量的数据。我们在营地中招募了124名患者，并在CAMCC中注册了115名患者。 CAMCC的家庭和患者继续致力于这项研究，我们预计他们会继续通过CAMCC/2参与。我们已经成功地招募了94％的原始营地队列进入坎克斯，我们将继续招募原始的CAMCCS/2营地队列。参加CAMCC的参与非常出色，94-97％的患者完成了CAMCC的学习访问，完成了完整窗口的关闭。